Walgreens collects more than 15,000 lbs. of unused, expired medications
HOUSTON — Walgreens’ Safe Medication Disposal Program, launched in September 2010 in partnership with Sharps Compliance, has collected more than 15,000 lbs. of unused or expired medications, Walgreens announced Monday.
“We estimate that more than 200 million lbs. of unused dispensed medications are disposed of improperly each year,” Sharps Compliance president and CEO David Tusa said.
“We are encouraged that many of our patients have taken advantage of this medication disposal opportunity,” stated Richard Ashworth, Walgreens VP pharmacy operations. “In addition to the environmental benefits, it addresses a common safety concern in communities. Customers are pleased to have a solution that allows them to be environmentally responsible and keep medications out of unintended hands with convenience and ease.”
As part of the program, U.S. Postal Service-approved envelopes are available at Walgreens for $3.99 for customers to place, seal and mail prescription or over-the-counter medications they no longer use to a facility for proper treatment. Controlled substances are excluded from this program due to current regulations. Postage is included in the cost of the envelope.
Pozen, AstraZeneca file suit against Dr. Reddy’s over generic Vimovo
CHAPEL HILL, N.C. — A generic drug maker is being sued for patent infringement for its version of a fixed-dose combination drug co-created by Pozen and AstraZeneca.
Pozen and AstraZeneca on Monday said that they have filed the suit in the U.S. District Court for the District of New Jersey against Dr. Reddy’s. The drug makers said Dr. Reddy’s is seeking approval from the Food and Drug Administration for its generic version of Vimovo (naproxen/esomeprazole magnesium) delayed-release tablets prior to the patent’s expiration date. Vimovo currently has regulatory exclusivity through April 30, 2013, Pozen and AstraZeneca said.
The filing of this patent infringement lawsuit by AstraZeneca and Pozen within 45 days of receipt of Dr. Reddy’s notice letter will result in the FDA automatically instituting a stay or bar of final approval of Dr. Reddy’s abbreviated new drug application for up to 30 months, or until a final court decision is entered in the infringement suit in favor of Dr. Reddy’s, whichever occurs first.
Lewis overhaul plays up Rx
Lewis Drug has a new face, which not only places a greater emphasis on the front end, but also boasts a larger, revamped pharmacy.
Those who have visited the newly opened store on Louise Avenue in Sioux Falls, S.D., undoubtedly will see the Lewis Drug store of the future, president and CEO Mark Griffin told Drug Store News in a recent interview.
The pharmacy area is about one-third larger than a typical Lewis Drug pharmacy and has been revamped. “Call it the new face of Lewis Drug. It incorporates an upscale environment, the beauty boutique, plank flooring in the pharmacy and an entertainment area in the pharmacy for waiting with flat-screen TVs and refreshments,” Griffin said. This new store also includes a “four seasons department,” which is a 4,000-sq.-ft. environmentally controlled room that can be used for various purposes throughout the year.
In addition, Lewis Drug has expanded its grocery departments in about a dozen locations. In its larger stores, about 2,000 sq. ft. to 3,000 sq. ft. have been dedicated to grocery items with a concentration on snack foods, grab-and-go items and frozen foods.